Clin2
NCT07144241Possibly a fitNot yet recruiting

Exosome therapy for type 2 diabetes

Type 2 Diabetes Mellitus

Part of Hormones & metabolism clinical trials.

This study tests whether exosomes (tiny particles from stem cells) can help improve blood sugar control in people with type 2 diabetes. It may offer a new way to manage the condition.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
50 people
Ages
40 years to 65 years
Study type
Interventional

Who can take part

  • You have been diagnosed with type 2 diabetes.
  • You are between 40 and 65 years old.
  • You are willing to participate and sign a consent form.
  • You do not have serious conditions like autoimmune diseases, cancer, or severe infections.
  • You are not taking blood thinners (anticoagulants) or immunosuppressive drugs.
  • You are not pregnant, and you do not have severe allergies to the treatment components.
  • You do not have chronic kidney disease requiring dialysis.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07396155Recruiting· Phase 1/Phase 2
Stem cell therapy for diabetic kidney disease

This trial tests whether stem cells from donated umbilical cords can safely help people with type 2 diabetes who also have kidney damage. It aims to see if this therapy can improve kidney function.

Yogyakarta
NCT07693036Recruiting· Phase 1/Phase 2
Exosomes from stem cells for type 2 diabetes

This trial tests if a type of stem cell product (exosomes) can safely and effectively help people with type 2 diabetes. Researchers will give infusions to see if it improves blood sugar control and pancreatic function.

Beijing
NCT07495956Not yet recruiting· Phase 1/Phase 2
Cell therapy for type 2 diabetes

This trial tests a new type of cell therapy called cfMSC for people with type 2 diabetes. The goal is to see if it can help control blood sugar better, possibly by helping the body use insulin more effectively.

Shenzhen, Guangdong
NCT06727721Recruiting· Phase 2
Stem cell therapy for hard-to-treat type 2 diabetes

This trial tests a new stem cell treatment for people with type 2 diabetes that is difficult to control with standard medications. The treatment uses a special kind of stem cell to try to improve blood sugar levels.

Shanghai
NCT06789302Not yet recruiting· Phase 2
Stem cell therapy for type 2 diabetes

This study tests an experimental stem cell treatment (DT2-SCT) to see if it can improve blood sugar control in people with type 2 diabetes who need insulin. It is a double-blind study, so neither you nor the study team will know if you get the real treatment or a placebo.

NCT07487467Recruiting
Stem cell therapy for type 2 diabetes

This trial tests using your own fat stem cells to help control blood sugar in type 2 diabetes. It might help if you have had diabetes for less than 10 years and are not on insulin.

São Jose Do Rio Preto, São Paulo

Hear when a new Type 2 Diabetes Mellitus trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.